Showing results (591-600 of 637) with videos related to

Sort By:
Pageof 64
Journal of Medicinal Chemistry|January 8, 2009
Design, synthesis, and cytoprotective effect of 2-aminothiazole analogues as potent poly(ADP-ribose) polymerase-1 inhibitorsWen-Ting Zhang, Jin-Lan Ruan, Peng-Fei Wu, et al.
Di 1 Jun Yi Da Xue Xue Bao = Academic Journal of the First Medical College of PLA|November 30, 2004
[Prevalence of hemorrhagic fever with renal syndrome virus in domestic pigs: an epidemiological investigation in Shandong province]Zhan-qing Yang, Shou-yi Yu, Jun Nie, et al.
Scientific Reports|January 10, 2017
Polydatin protects the respiratory system from PM<sub>2.5</sub> exposureXiao-Dan Yan, Qi-Ming Wang, Cai Tie, et al.
Zhonghua Yi Xue Za Zhi|January 13, 2006
[Analysis of ABL tyrosine kinase point mutations in imatinib treated chronic myelogenous leukemia patients]Ya-zhen Qin, Yan-rong Liu, Jin-lan Li, et al.
Genetica|May 8, 2016
Structure and expression of phosphoglucan phosphatase genes of Like Sex Four1 and Like Sex Four2 in barleyJian Ma, Shang Gao, Qian-Tao Jiang, et al.
Clinical and Translational Medicine|January 3, 2026
Feedback regulation between histone H3 lysine 18 lactylation and TROP2-mediated glycolysis drives metastatic progression of colorectal cancerWeifeng Wang, Yuxiang Deng, Weihao Li, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|April 25, 2013
[A multicenter comparison study on the quantitative detection of bcr-abl (P210) transcript levels in China]Ya-zhen Qin, Hui Cheng, Jian-nong Cen, et al.
International Journal of Molecular Medicine|January 23, 2026
[Retracted] DDAH2 alleviates myocardial fibrosis in diabetic cardiomyopathy through activation of the DDAH/ADMA/NOS/NO pathway in ratsZhen-Dong Zhu, Ji-Ming Ye, Xue-Mei Fu, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|June 22, 2010
[Abnormal expression of programmed cell death 5 gene in multiple myeloma patients]Li Bao, Guo-Rui Ruan, Xi-Jing Lu, et al.
Leukemia Research|March 10, 2015
Frequency and allele burden of CALR mutations in Chinese with essential thrombocythemia and primary myelofibrosis without JAK2(V617F) or MPL mutationsNing Li, Qiu-Mei Yao, Robert Peter Gale, et al.
Pageof 64